Litcius/Paper detail

1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trial

Thomas E. Bolhuis, Diane Marsman, Alfons A den Broeder, Nathan den Broeder, Aatke van der Maas

2023The Lancet Rheumatology35 citationsDOI

Topics & Concepts

Polymyalgia rheumaticaMedicineRituximabInternal medicineRheumatismPlaceboRandomized controlled trialRheumatologyIntention-to-treat analysisPhysical therapySurgeryGiant cell arteritisLymphomaDiseaseVasculitisAlternative medicinePathologyVasculitis and related conditionsSystemic Sclerosis and Related DiseasesHeparin-Induced Thrombocytopenia and Thrombosis
1-year results of treatment with rituximab in polymyalgia rheumatica: an extension study of a randomised double-blind placebo-controlled trial | Litcius